GenVec, Inc. is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, RSV, seasonal and pandemic flu, and foot and mouth disease. GenVec also discovers and develops novel treatments for hearing loss and balance disorders through a worldwide collaboration with Novartis.

Corporate Counsel
Hogan & Hartson LLP
Baltimore, MD

Independent Accountants
KPMG LLP
Washington, D.C.

Investor Relations Contact
Douglas J. Swirsky
Senior Vice President and Chief Financial Officer
65 West Watkins Mill Road
Gaithersburg, MD 20878
240-632-5510
Email Investor Relations here

Media Contact
Douglas J. Swirsky
Senior Vice President and Chief Financial Officer
65 West Watkins Mill Road
Gaithersburg, MD 20878
240-632-5510
Email Investor Relations here